A. Blasina et al., THE ROLE OF INHIBITORY PHOSPHORYLATION OF CDC2 FOLLOWING DNA-REPLICATION BLOCK AND RADIATION-INDUCED DAMAGE IN HUMAN-CELLS, Molecular biology of the cell, 8(6), 1997, pp. 1013-1023
It has been suggested that the survival response of p53 defective tumo
r cells to agents that inhibit DNA replication or damage DNA may be la
rgely dependent on cell cycle checkpoints that regulate the onset of m
itosis. In human cells, the mitosis-inducing kinase CDC2/cyclin B is i
nhibited by phosphorylation of threonine-14 and tyrosine-15, but the r
oles of these phosphorylations in enforcing checkpoints is not known.
We have investigated the situation in a human cervical carcinoma cell
line (HeLa cells) and found that low level expression of a mutant nonp
hosphorylatable form of CDC2 abrogates regulation of the endogenous CD
C2/cyclin B. Disruption of this pathway is toxic and renders cells hig
hly sensitive to killing by DNA damage or by inhibition of DNA replica
tion. These findings establish the importance of inhibitory phosphoryl
ation of CDC2 in the survival mechanism used by human cells when expos
ed to some of the most common forms of anticancer therapy.